Is the price fair?
What CC's price assumes
Today's price asks for 1.8% free cash flow growth a year; over the last three years The Chemours Company delivered 23%, less than the record.
0.57
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 6.7%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- +1.8%
Growth the price implies · The price pays for +1.8% free cash flow growth a year for a decade; the business has delivered +23% a year over the last three.
- Price / book
- 15.4
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 15.4
- EV / EBIToperating margin −1.9%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 1.18
- Free cash flow, trailing twelve months
- $218M
- Market capitalisation
- $3.27B
- 3-year revenue growth
- −2.9%
- 3-year free cash flow growth
- +23%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #26 of 36 by Smart Score